UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 25, 2006

INTRALASE CORP.

(Exact name of registrant as specified in its charter)


Delaware	000-50939	38-3380954
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)


9701 Jeronimo, Irvine, CA		92618
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (949) 859-5230

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02(d)

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On July 19, 2006, the Board of Directors of IntraLase Corp. (the “Company”) nominated Michael Ball for a seat on the Company’s Board of Directors and, on July 25, 2006, Mr. Ball agreed to join the Company’s Board. Mr. Ball replaces Mark Lortz, whose intention to resign was previously announced by the Company. Mr. Lortz’s resignation became effective upon Mr. Ball’s appointment and acceptance. A copy of the Company’s press release announcing Mr. Ball’s election is attached hereto as Exhibit 99.1 to this Form 8-K and incorporated by reference.

Item 9.01

Financial Statements and Exhibits

(d)

Exhibits


*Exhibit Number*		*Description*
99.1		Press Release dated July 25, 2006

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


				INTRALASE CORP.
				(Registrant)

Date: July 31, 2006				/s/ Shelley B. Thunen
				Shelley B. Thunen
				Executive Vice President & Chief Financial Officer

EXHIBIT INDEX


Exhibit No.		Description
99.1		Press Release dated July 25, 2006

INTRALASE CORP 8-K